Molecular and cellular mechanisms of tight junction dysfunction in the irritable bowel syndrome

Molecular Medicine Reports

Volumn 12, Issue 3, 2015, Pages 3257-3264

  Cheng, Peng ^a   Yao, Jianning ^a   Wang, Chunfeng ^a   Zhang, Lianfeng ^a   Kong, Wuming ^b  

^a ZHENGZHOU UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Claudin 1; Irritable bowel syndrome; Tight junctions

Indexed keywords

CLAUDIN 1;

ADULT; AGED; ARTICLE; CELL STRUCTURE; CELL VACUOLE; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; ELECTRON MICROSCOPY; ENZYME MECHANISM; EXTRAVASATION; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MAST CELL; MIDDLE AGED; NEUROSECRETORY CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TIGHT JUNCTION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; ADOLESCENT; COMPLICATION; INTESTINE; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CLAUDIN-1; CONSTIPATION; DIARRHEA; FEMALE; HUMANS; INTESTINAL MUCOSA; INTESTINES; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; TIGHT JUNCTIONS; YOUNG ADULT;

EID: 84935495522     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3808     Document Type: Article

References (27)

1. Garrett WS, Gordon JI and Glimcher LH: Homeostasis and inflammation in the intestine. Cell 140:859-870, 2010.
2. Turner JR: Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9:799-809, 2009.
3. Mayer EA and Tillisch K: The brain-gut axis in abdominal pain syndromes. Annu Rev Med 62:381-396, 2011.
4. Clayburgh DR, Shen L and Turner JR: A porous defense: the leaky epithelial barrier in intestinal disease. Lab Invest 84:282-291, 2004.
5. Tsukita S, Furuse M and Itoh M: Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2:285-293, 2001.
6. Forster C: Tight junctions and the modulation of barrier function in disease. Histochem Cell Biol 130:55-70, 2008.
7. Harhaj NS and Antonetti DA: Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol 36:1206-1237, 2004.
8. Tsukita S and Furuse M: The structure and function of claudins, cell adhesion molecules at tight junctions. Ann N Y Acad Sci 915:129-135, 2000.
9. Groschwitz KR and Hogan SP: Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol 124:3-20; quiz 21-22, 2009.
10. Van Itallie CM and Anderson JM: Claudins and epithelial paracellular transport. Annu Rev Physiol 68:403-429, 2006.
11. Schneeberger EE and Lynch RD: The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 286:C1213-1228, 2004.
12. Turksen K and Troy TC: Barriers built on claudins. J Cell Sci 117:2435-2447, 2004.
13. Saitou M, Furuse M, Sasaki H, Schulzke JD, Fromm M, Takano H, Noda T and Tsukita S: Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 11:4131-4142, 2000.
14. Dang J, Ardila-Hani A, Amichai MM, Chua K and Pimentel M: Systematic review of diagnostic criteria for IBS demonstrates poor validity and utilization of Rome III. Neurogastroenterol Motil 24:853-e397, 2012.
15. Gitter AH, Bendfeldt K, Schulzke JD and Fromm M: Leaks in the epithelial barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis. FASEB J 14:1749-1753, 2000.
16. Zeissig S, Burgel N, Gunzel D, et al: Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 56:61-72, 2007.
17. Yuan B, Zhou S, Lu Y, Liu J, Jin X, Wan H and Wang F: Changes in the expression and distribution of claudins, increased epithelial apoptosis, and a mannan-binding lectin-associated immune response lead to barrier dysfunction in dextran sodium sulfate-induced rat colitis. Gut Liver: Feb. 26, 2015 (Epub ahead of print).
18. Kyoko OO, Kono H, Ishimaru K, Miyake K, Kubota T, Ogawa H, Okumura K, Shibata S and Nakao A: Expressions of tight junction proteins Occludin and Claudin-1 are under the circadian control in the mouse large intestine: Implications in intestinal permeability and susceptibility to colitis. PLoS One 9:e98016, 2014.
19. Barbara G, Zecchi L, Barbaro R, et al: Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. J Clin Gastroenterol 46(Suppl):S52-55, 2012.
20. Barbara G: Mucosal barrier defects in irritable bowel syndrome. Who left the door open? Am J Gastroenterol 101:1295-1298, 2006.
21. Santos J, Guilarte M, Alonso C and Malagelada JR: Pathogenesis of irritable bowel syndrome: the mast cell connection. Scand J Gastroenterol 40:129-140, 2005.
22. Guilarte M, Santos J, de Torres I, et al: Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut 56:203-209, 2007.
23. Cenac N, Andrews CN, Holzhausen M, et al: Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest 117:636-647, 2007.
24. Barbara G, Wang B, Stanghellini V, et al: Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 132:26-37, 2007.
25. Iweala OI and Nagler CR: Immune privilege in the gut: the establishment and maintenance of non-responsiveness to dietary antigens and commensal flora. Immunol Rev 213:82-100, 2006.
26. Wisner DM, Harris LR III, Green CL and Poritz LS: Opposing regulation of the tight junction protein claudin-2 by interferon-gamma and interleukin-4. J Surg Res 144:1-7, 2008.
27. Jacob C, Yang PC, Darmoul D, et al: Mast cell tryptase controls paracellular permeability of the intestine. Role of protease-activated receptor 2 and beta-arrestins. J Biol Chem 280:31936-31948, 2005.